MARCOLIN , Riccardo

Last name: MARCOLIN

First name: Riccardo

2019 (v1)

Publication

Metadata-only

Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD-driven salvage approach

Guolo, Fabio Minetto, Paola Clavio, Marino

No description

Uploaded on: April 14, 2023
2020 (v1)

Publication

Metadata-only

Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas

Manconi, Lorenzo Coviello, Elisa Canale, Filippo

Cisplatin-containing salvage regimens followed by autologous hematopoietic stem cell (HSC) transplantation are the current standard of care for relapsed or refractory (R/R) lymphomas. We retrospectively analyzed efficacy and stem cell mobilizing activity of oxaliplatin, cytarabine, dexamethasone and rituximab (R-DHAOx) in 53 R/R diffuse large B...

Uploaded on: April 14, 2023
2021 (v1)

Publication

Metadata-only

Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells

Guolo, Fabio Minetto, Paola Pesce, Silvia

Immune checkpoint inhibitors (CI) have demonstrated clinical activity in Hodgkin Lymphoma (HL) patients relapsing after autologous stem cell transplantation (ASCT), although only 20% complete response (CR) rate was observed. The efficacy of CI is strictly related to the host immune competence, which is impaired in heavily pre-treated HL...

Uploaded on: January 10, 2024

MARCOLIN , Riccardo

Recent uploads